Biological interpretation of relative risk

Area of Science:

• Epidemiology
• Biostatistics
• Clinical Research

Background:

• Assessing the clinical importance of study results is crucial but hindered by unclear biological interpretability of epidemiological measures.
• Relative risk is often viewed as a statistical association, neglecting its potential as a measure of biological effect.
• Statistically non-significant relative risk estimates are frequently disregarded, limiting clinical insight.

Purpose of the Study:

• To clarify the biological interpretability of epidemiological effect measures, specifically relative risk.
• To propose a framework for evaluating the clinical importance of study findings beyond statistical significance.
• To enhance the directed interpretation of epidemiological data by focusing on biological effects.

Main Methods:

• Utilizing a theoretical framework where outcome rates from two comparison groups represent different effects within the same population.
• Employing a placebo group to estimate background outcome rates.
• Deriving an estimate of excess cases attributable to an intervention from the relative risk.

Main Results:

• A method is presented to derive a biological entity from relative risk, representing excess cases due to an intervention.
• This biologically derived measure is more amenable to clinical importance assessment than statistical associations.
• The approach facilitates a more focused interpretation of results based on ancillary hypotheses.

Conclusions:

• Biological interpretability of epidemiological measures like relative risk is key to assessing clinical importance.
• Moving beyond statistical significance to measure biological effects provides a more robust evaluation of study findings.
• This framework supports a more directed and clinically relevant interpretation of epidemiological research.